Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study the efficacy and safety of Visonac PDT in patients from
9 to 35 years old with Aktilite® CL512. Patients was randomized to Visonac or vehicle cream
without occlusion and red light(dose: 37J/cm2)